Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05774639
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2023-02-25
Brief Title:
Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR Omalizumab in Adults With Chronic Idiopathic Urticaria
Sponsor:
Organization:
Kashiv BioSciences LLC